Literature DB >> 2694146

The use of disease modifying antirheumatic drugs in the management of rheumatoid arthritis.

L E Hart1, P Tugwell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2694146      PMCID: PMC2429570          DOI: 10.1136/pgmj.65.770.905

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  48 in total

1.  Auranofin or D-penicillamine in the treatment of rheumatoid arthritis.

Authors:  M C Hochberg
Journal:  Ann Intern Med       Date:  1986-10       Impact factor: 25.391

Review 2.  D-penicillamine: chemistry and clinical use in rheumatic disease.

Authors:  H E Howard-Lock; C J Lock; A Mewa; W F Kean
Journal:  Semin Arthritis Rheum       Date:  1986-05       Impact factor: 5.532

3.  Current practice in antimalarial drug prescribing in rheumatoid arthritis.

Authors:  N Bellamy; P M Brooks
Journal:  J Rheumatol       Date:  1986-06       Impact factor: 4.666

Review 4.  Antimalarials in rheumatology: efficacy and safety.

Authors:  W Maksymowych; A S Russell
Journal:  Semin Arthritis Rheum       Date:  1987-02       Impact factor: 5.532

5.  Effect of sulphasalazine on the radiological progression of rheumatoid arthritis.

Authors:  T Pullar; J A Hunter; H A Capell
Journal:  Ann Rheum Dis       Date:  1987-05       Impact factor: 19.103

Review 6.  Methotrexate in rheumatoid arthritis. Indications, contraindications, efficacy, and safety.

Authors:  P Tugwell; K Bennett; M Gent
Journal:  Ann Intern Med       Date:  1987-09       Impact factor: 25.391

7.  The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis.

Authors:  J M Kremer; J K Lee
Journal:  Arthritis Rheum       Date:  1986-07

8.  Long-term treatment of rheumatoid arthritis with sulphasalazine, gold, or penicillamine: a comparison using life-table methods.

Authors:  R D Situnayake; K A Grindulis; B McConkey
Journal:  Ann Rheum Dis       Date:  1987-03       Impact factor: 19.103

9.  Pulmonary disease during the treatment of rheumatoid arthritis with low dose pulse methotrexate.

Authors:  C W Carson; G W Cannon; M J Egger; J R Ward; D O Clegg
Journal:  Semin Arthritis Rheum       Date:  1987-02       Impact factor: 5.532

10.  Long term progression of joint damage in rheumatoid arthritis.

Authors:  D L Scott; B L Coulton; A J Popert
Journal:  Ann Rheum Dis       Date:  1986-05       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.